生物信息学分析揭示了与喘严重程度相关的潜在分子机制,并确定了与GABAergic相关的途径,作为Th2-高内型喘的潜在治疗方法
Ruisong Gong1, Zihao Wang2, Gang Tan1
1Department of Anesthesiology, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing, 100730, China.
Heliyon
|April 8, 2024
概括
喘的严重程度在T助手2 (Th2) 高和Th2-低的内型之间有所不同. 与胺黄油酸 (GABA) 途径相关的基因为Th2高喘提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
- 系统生物学 系统生物学
背景情况:
- 喘被分为T助手2 (Th2) -高和Th2-低的内型,影响临床表现和治疗.
- 在喘中这些Th2内型的基础上的分子机制仍然不完全理解.
研究的目的:
- 研究喘中Th2内型的分子机制.
- 确定与Th2内型相关的关键基因和通路.
主要方法:
- 分析了来自喘患者的转录数据和临床信息.
- 重量基因同表达网络分析 (WGCNA) 确定了基因模块.
- 蛋白与蛋白相互作用 (PPI) 网络被构建用于识别枢纽基因.
- 进行了功能丰富和免疫细胞丰度分析.
主要成果:
- 在"粉红色"模块基因和Th2内型之间发现了显著的相关性.
- 在Th2内型中确定了151个差异表达基因 (DEG),其中66个与"粉红色"模块重叠.
- 确定了10个调节Th2内型的枢纽基因.
- 在Th2高喘中,枢纽基因与玛-氨基黄油酸 (GABA) 途径有显著的关联.
结论:
- 喘的严重程度受到不同的Th2内型的影响.
- 与GABAergic通路相关的枢纽基因为Th2-高喘提供了潜在的治疗点.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
391
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
391
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
284
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists
256
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
256


